Pharma

Your Article Summary

See Latest Articles

FDA approves Exforge HCT - the only high blood pressure treatment to combine three medications in a single pill
Novartis, 05/01/09

The US Food and Drug Administration (FDA) has approved Exforge HCT, the only single pill to combine the three most prescribed high blood pressure treatments in their classes in the US[3]: the calcium channel blocker amlodipine, the angiotensin receptor blocker valsartan, and the diuretic hydrochlorothiazide. Exforge HCT is an important new option for patients who have tried taking dual combinations of these classes of blood pressure medications without success.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Multaq Approved in the European Union for Patients with Atrial Fibrillation
Sanofi-aventis, 12/01/09

FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09

FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS
BioMarin, 12/01/09

 See all of Drug/Product Approvals